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ABSTRACT
Objective This systematic review and meta- analysis aims 
to systematically analyse the association of overweight 
and obesity with health service utilisation during childhood.
Data sources PubMed, MEDLINE, CINAHL, EMBASE and 
Web of Science.
Methods Observational studies published up to May 2020 
that assessed the impact of overweight and obesity on 
healthcare utilisation in children and adolescents were 
included. Studies were eligible for inclusion if the included 
participants were ≤19 years of age. Findings from all 
included studies were summarised narratively. In addition, 
rate ratios (RRs) and 95% CIs were calculated in a meta- 
analysis on a subgroup of eligible studies.
Outcome measures Included studies reported 
association of weight status with healthcare utilisation 
measures of outpatient visits, emergency department (ED) 
visits, general practitioner visits, hospital admissions and 
hospital length of stay.
Results Thirty- three studies were included in the 
review. When synthesising the findings from all studies 
narratively, obesity and overweight were found to be 
positively associated with increased healthcare utilisation 
in children for all the outcome measures. Six studies 
reported sufficient data to meta- analyse association of 
weight with outpatient visits. Five studies were included in 
a separate meta- analysis for the outcome measure of ED 
visits. In comparison with normal- weight children, rates 
of ED (RR 1.34, 95% CI 1.07 to 1.68) and outpatient visits 
(RR 1.11, 95% CI 1.02 to 1.20) were significantly higher 
in obese children. The rates of ED and outpatient visits by 
overweight children were only slightly higher and non- 
significant compared with normal- weight children.
Conclusions Obesity in children is associated with 
increased healthcare utilisation. Future research should 
assess the impact of ethnicity and obesity- associated 
health conditions on increased healthcare utilisation in 
children with overweight and obesity.
PROSPERO registration number CRD42018091752
INTRODUCTION
In recent years, childhood obesity has 
emerged as one of the greatest paediatric 
public health concerns worldwide. According 
to latest report by WHO, in 2016 over 
41 million children under the age of 5, and 
over 340 million children and adolescents 
aged 5–19, were overweight or obese glob-
ally.1 The situation is of serious concern in the 
UK, which is reported to be the most obese 
country in Western Europe by the Organisa-
tion of Economic Co- operation and Devel-
opment.2 Recent reports have shown that 1 
in 5 children in the reception year (age 4–5) 
and 1 in 3 children in year 6 (age 12–13) are 
obese or overweight in the UK.3
The burden of obesity- related morbidity 
is well documented. Extensive research has 
shown that individuals who are obese or over-
weight in their childhood are more likely to 
stay overweight or obese in adult life,4 leading 
to an increased risk of developing cardiomet-
abolic conditions such as type 2 diabetes, isch-
aemic heart disease and stroke.4–6 In addition, 
the increasing prevalence of overweight and 
obesity in childhood has led to an increase in 
the incidence of previously unusual metabolic 
imbalances at this age, and a rise in associated 
diseases such as type 2 diabetes and metabolic 
syndrome.7–11
Given the aforementioned associations, it 
could be inferred that individuals with over-
weight and obesity would experience greater 
morbidity compared with individuals of 
normal weight, leading to increased health-
care utilisation. Several studies have reported 
a strong association between overweight 
Strengths and limitations of this study
 ► A systematic search of the published literature in 
English language in major databases up to May 
2020 was conducted.
 ► Risk of bias was assessed in the included studies 
and the review is reported according to Preferred 
Reporting Items for Systematic reviews and Meta- 
Analysis guidelines.
 ► Search of grey literature, unpublished studies and 
studies published in a language other than English 
was not conducted.
 ► Meta- regression analysis could not be conducted.
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
 on O
ctober 22, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-035676 on 8 O
ctober 2020. D
ow
nloaded from
 
2 Hasan T, et al. BMJ Open 2020;10:e035676. doi:10.1136/bmjopen-2019-035676
Open access 
or obesity and increased healthcare use.12–14 However, 
majority of these have quantified this association by 
assuming that individuals with obesity will start accruing 
the obesity- associated increased healthcare use at or after 
a certain age, with most ignoring the healthcare use 
during childhood.12 15
In order to address this issue, we conducted a systematic 
review and meta- analysis with the objective of evaluating the 
association of overweight or obesity with healthcare utilisa-
tion in children, pooling the available evidence from eligible 
studies. In this review, we also aim to identify the obesity- 
associated conditions that may explain the association of 
overweight or obesity with increased healthcare utilisation.
METHODS
This review is reported in accordance with the Preferred 
Reporting Items for Systematic reviews and Meta- Analysis 
(PRISMA) recommendations.16 The protocol for this review 
is registered with PROSPERO—International Prospective 
Register of Systematic Reviews. The PRISMA checklist is 
provided as online supplemental file 1.
Literature search
A systematic literature search was performed in five electronic 
databases (PubMed, Medline, EMBASE, Web of Science and 
CINAHL) from inception to July 2018. An update of data-
base searches was conducted in May 2020. This search update 
covered the full data range from inception to May 2020, and 
records found in the previous search were removed based 
on the methods described by Bramer and Bain.17 The search 
focused on studies reporting association between weight 
status and healthcare utilisation in children. Only studies 
published in English language were considered for inclu-
sion. The searches were conducted by assembling terms that 
could relate to the three main components of the review: 
‘children or adolescents’, ‘obesity or overweight’ and ‘health-
care utilisation’. These terms comprised keywords, text terms 
or medical subject headings appropriate for each literature 
database. A copy of the searches conducted to identify studies 
is given in online supplemental file 2. We also searched the 
reference lists of screened publications to look for additional 
articles. A forward and backward reference search for all 
the studies meeting the inclusion criteria was carried out to 
identify any other relevant studies. Research reported in grey 
literature was not searched. Conference abstracts and review 
articles were not eligible for inclusion. However, reference 
lists of screened review articles were checked for potentially 
relevant studies.
Study eligibility
Observational studies assessing the impact of overweight or 
obesity on healthcare utilisation in children were included 
in the review. Studies were excluded based on the following 
criteria: studied the association for underweight children 
only; included participants over 19 years of age; included 
participants both less than and greater than 19 years of age 
but did not stratify the results by age groups; review articles. 
The decision for the inclusion of children/adolescents up to 
the age of 19 years was made based on WHO’s definition of 
a child and adolescent.18 In addition, instead of restricting 
the inclusion criteria to studies using predefined standard 
body mass index (BMI) cut- offs for childhood overweight 
(sex- specific and age- specific BMI ≥85th centile and <95th 
centile) and obesity (sex- specific and age- specific BMI ≥95th 
centile),19 20 a decision was made to include the study- specific 
definitions with the aim of assessing the effect of varying 
BMI cut- offs on the association of overweight or obesity with 
healthcare utilisation.
Study selection
Titles and abstracts of records retrieved through literature 
search up to July 2018 were screened by a single reviewer (TH) 
with a random sample of 10% of these studies screened by a 
second reviewer (TSA). Studies were then full text screened 
by the first reviewer (TH) to assess their eligibility for inclu-
sion in the review. A random sample of 10% of these full- text 
studies was also screened by the second reviewer (TSA). The 
level of agreement between the two reviewers at each stage 
was assessed by Cohen’s kappa score. The score was classi-
fied as follows:<0.20 indicated a poor agreement; 0.21–0.40 a 
fair agreement; 0.41–0.60 a moderate agreement; 0.61–0.80 
a good agreement; 0.81–1.00 a very good agreement.21 All 
disagreements were resolved through discussion between 
the two reviewers and by consulting a third reviewer (LKF) 
if required.
Additional records retrieved from the search update in 
May 2020 were screened for title, abstract and full text by 
the first reviewer (TH).
Data extraction and risk of bias assessment
A customised data extraction form was designed to extract 
following information from each study: first author’s 
surname, year of publication, study design, country, sample 
size, age range, time frame, definition of obesity/overweight, 
outcome measures and effect size for healthcare use. Data 
for each study were extracted by the first reviewer (TH) and 
reviewed by the second reviewer (TSA). Any discrepancies 
were discussed and resolved through consensus between the 
reviewers.
The Quality Assessment tool for Observational Cohort 
and Cross- sectional studies by the National Heart and Lung 
Institute (NHLBI) was used to assess the quality and risk 
of bias of each included study.22 This assessment tool rates 
study quality along 14 criteria, with three possible outcomes 
for each question: ‘Yes’, ‘No’ and ‘Cannot determine/Not 
reported/Not applicable’. For a response of ‘Yes’, a score of 
one was assigned against the criteria, whereas a score of zero 
was assigned for any answer other than ‘Yes’. Each study was 
then rated Good, Fair or Poor based on a score ranging from 
0 to 14; where a ‘good’ study was considered to have the least 
risk of bias, ‘fair’ was susceptible to some bias and ‘poor’ indi-
cated a high risk of bias.
Narrative synthesis
Due to the diverse nature of healthcare utilisation outcomes, 
measures of effect and lack of appropriate or sufficient data 
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in the majority of studies to statistically analyse these effect 
size measurements, a decision was made to summarise the 
findings of the included studies narratively. A narrative 
synthesis was developed to explain the impact of weight 
status on all the reported measures of health service use in 
different studies: emergency department visits, outpatient 
visits, general practitioner (GP) visits, hospital admissions 
and length of stay (LOS). In addition, potential sources of 
heterogeneity across studies were explored.
Statistical analysis
The ‘meta’ command in Stata V.16.1 23 was used to generate 
meta- analysis for rate ratios (RRs) of healthcare utilisation in 
obese and overweight children, using normal- weight children 
as a reference. Studies that reported RRs with corresponding 
measures of precision (95% CIs or SEs) were included in 
the meta- analysis. In addition, studies with appropriate raw 
data to compute crude RRs were eligible for inclusion in the 
meta- analysis. Meta- analysis uses effect sizes in a metric that 
makes them closest to normally distributed; therefore, before 
undertaking the analysis in Stata, RRs were log transformed 
and corresponding SEs were computed from effect sizes 
and 95% CIs using the Comprehensive Meta- Analysis soft-
ware V.3.24 Afterwards, a random- effects meta- analysis with 
Hartung- Knapp- Sidik- Jonkman method was carried out.25 26 
The error rates for this method have consistently been shown 
to be more robust than the more commonly used DerSimo-
nian and Laird method, particularly when there are small 
number of studies in the meta- analysis.27
Publication bias was assessed using funnel plots; 
however, due to the number of studies included in the 
analysis being less than 10, statistical tests for funnel 
plot asymmetry were not performed.28 Heteroge-
neity among studies was assessed using the I2 statistic. 
Based on the interpretation provided in the Cochrane 
Handbook for Systematic Reviews, heterogeneity in 
this review is considered substantial if I2 >50%.29
Patient and public involvement
No patients or members of public were involved in the 
conduct and reporting of this review.
RESULTS
Study selection
A PRISMA flow diagram for study selection is shown in 
figure 1. The search of electronic databases up to July 
2018 identified 36 077 records. After removal of dupli-
cates, 18 966 studies were screened by titles and abstracts. 
A random sample of 1900 studies (10%) was also reviewed 
by the second reviewer. The level of agreement between 
reviewers at this stage was reflected by a Cohen’s kappa 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) study selection diagram.
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score of 0.86. Full texts of 578 studies were screened by 
the first reviewer with a random sample of 60 studies 
(10%) also reviewed by the second reviewer. Cohen’s 
kappa score for level of agreement at this stage was 0.67, 
which indicated a good agreement. Twenty- six articles 
were eligible for inclusion at this stage.
The search update in May 2020 identified 8504 additional 
articles, of which 4 were eligible for inclusion. Three addi-
tional articles were identified through searching the refer-
ence lists of screened systematic reviews. Overall, 33 studies 
were eligible for inclusion. All these studies were included 
in the narrative synthesis, but only six were included in the 
meta- analysis.
Study characteristics
The basic characteristics of included studies are summarised 
in table 1. The majority of these studies (n=20) were 
conducted in the USA. Twenty- three of the included studies 
were cohort studies. Nine of the remaining studies used cross- 
sectional methods, while one study was a case–control study 
(table 1). Multiple studies reported data from two surveys/
cohorts. The Medical Expenditure Panel Survey (MEPS) is 
reported in five studies30–34 and the German Interview and 
Examination Survey for Children and Adolescents (KiGGS) 
is reported in two studies.35 36 As studies from the same 
survey/cohort reported data for different years or different 
outcome measures, decision was made to analyse the data for 
each individual study.
Table 1 summarises the measures of healthcare utilisation 
reported across the included studies. The most commonly 
reported outcome measures were emergency department 
(ED) visits (n=10)32–34 37–43 and outpatient (n=11) visits 
(including primary care and specialty visits).32–34 36–41 43 44 
Seven studies reported on healthcare use associated with respi-
ratory diseases,41 44–49 two reported on musculoskeletal condi-
tions44 50 and two on conditions concerning mental health.37 44 
The rest of the studies analysed the overall healthcare use in 
children with no reporting on reasons for utilisation. The 
studies represented children between 1 and 19 years of age. 
Table 1 shows that seven studies calculated BMI from anthro-
pometric measurements (height and weight) based on self- 
reported or parent- reported data.30 32–34 51 52 In all other 
studies, heights and weights were either measured as part of 
the study or recorded from the health facility records. Two 
studies reported data on weight only and used weight:age 
ratio to define obesity or overweight.53 54 In addition, different 
variables were adjusted for in the multivariate analysis in 
respective studies. These variables are listed in table 1.
Risk of bias
The response for each study against the criteria in 
NHLBI’s quality assessment tool to critically appraise 
the internal validity is shown in table 2. Fourteen studies 
scored a ‘good’ rating, sixteen had a ‘fair’ rating, while 
three had a ‘poor’ rating. The studies included in the 
meta- analysis were either of ‘good’ or ‘fair’ quality; there-
fore, weighting based on quality assessment was not done 
in the meta- analysis. However, quality assessment was 
used to weigh the strength of evidence during narrative 
synthesis.
Narrative synthesis and meta-analysis
Findings from all included studies were synthesised narra-
tively for each outcome measure of healthcare utilisation. 
A subgroup synthesis was done by dividing studies based 
on BMI cut- offs, ethnicity and method of anthropometric 
measurement.
Six studies were included in the meta- analysis.37 38 40 41 43 55 
All of these studies were cohort studies (table 1). All six 
studies reported an association between weight status and 
outpatient visits and were included in the meta- analysis 
for outcome measure of outpatient visits. Five of these six 
studies also reported on association of weight status with 
ED visits, and were therefore included in a separate meta- 
analysis for outcome measure of ED visits.37 38 40 41 43 In 
addition, five of these37 38 41 43 55 used a similar definition 
to define obesity (age- specific and sex- specific BMI ≥95th 
percentile) while one study40 defined it as age- specific 
and sex- specific BMI z- score ≥2, which also corresponds 
to BMI ≥95th percentile.19 Moreover, five studies included 
in the meta- analysis for ED visits were conducted in the 
USA. The sixth study, which was part of analysis for outpa-
tient visits, was conducted in Canada. For one study,38 
the appropriate effect sizes with corresponding SEs 
were calculated using the available raw data. One study 
assessed healthcare use over 1- year and 3- year periods. A 
decision was made to include data for 1- year period due 
to larger sample size as many participants were lost to 
follow- up by the end of the 3- year period.37 Figures 2 and 
3 show the forest plots for meta- analysis with outcome 
measures of ED visits and outpatients visits, respectively. 
Online supplemental figures 1 and 2 show forest plots for 
ED and outpatient visits in obese children compared with 
normal- weight children calculated using the pre- specified 
adjusted RRs reported by individual studies. Due to a 
small number of studies eligible for inclusion in the meta- 
analysis and limited to no data available on key covariates, 
it was not possible to perform a subgroup analysis.
ED visits
Ten studies reported ED visits as an outcome measure 
for healthcare utilisation.32–34 37–41 43 53 In both obese and 
overweight children compared with normal- weight chil-
dren, the general direction of association was an increase 
in visits; however, variability in the strength and direction 
of association was reported. For obese children compared 
with normal- weight children, five studies reported a 
significant increase in ED visits.32 33 40 41 43 Three studies 
reported a non- significant increase in ED visits.37–39 In 
addition, one study reported a non- significant decrease 
of ED visits in obese children 6–11 years old, while for 
obese children aged 12–17 years, a significant increase in 
visits was reported.34 For overweight children, four studies 
reported a significant increase in ED visits compared with 
normal- weight children.32 33 41 43 Two studies reported a 
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non- significant increase34 38 and two studies reported a 
non- significant decrease.37 40
In the five studies included in the meta- analysis for ED 
visits, obese children were significantly more likely to visit 
EDs compared with normal- weight children (figure 2A). 
The associated effect size (RR) was 1.34 (95% CI 1.07 to 
1.68). The effect size for overweight versus healthy weight 
was RR 1.11 (95% CI 0.92 to 1.33) (figure 2B). The I2 
statistic showed substantial between- study heterogeneity 
for obese versus normal weight (I2=94.3%, p<0.01) and 
overweight versus normal weight (I2=92.5%, p<0.01).
On visual inspection of funnel plot asymmetry, there is 
a possibility of publication bias, with a small sized study 
reporting high RRs for obese children (online supple-
mental figure 3). A statistical test for publication bias was 
not performed due to small number of studies (n<10).
Outpatient visits
Eleven studies reported outpatient visits as a measure 
of healthcare utilisation.32–34 36–41 43 44 In obese children 
compared with normal- weight children, the general direc-
tion of association was an increase in visits; however, vari-
ability in the strength of association was reported. Seven 
studies reported a significant increase in outpatient visits 
for obese children,32 33 37 39–41 43 while four studies reported 
a non- significant increase.34 36 38 44 For overweight children 
compared with normal- weight children, three studies 
reported a significant increase in outpatient visits.37 41 43 
Five studies reported a non- significant increase32–34 36 38 
while two studies reported a non- significant decrease in 
outpatient visits.40 44
Pooled unadjusted RRs for obese versus normal weight 
and overweight versus normal weight were 1.11 (95% CI 
1.02 to 1.20) and 1.02 (95% CI 0.98 to 1.08), respectively 
(figure 3A,B). Significant between- study heterogeneity 
was observed for both obese versus normal- weight chil-
dren (I2=87.6%, p<0.01) and overweight versus normal- 
weight children (I2=73%, p<0.01).
Visual inspection of funnel plot asymmetry for outpa-
tient visits in obese children suggests publication bias 
(online supplemental figure 4). Statistical tests to assess 
publication bias were not performed due to the small 
number of studies (n<10).
Hospital admissions and LOS
Seven studies reported hospital admissions as a measure 
of healthcare use.37 39 41 42 44 49 56 One study reported a 
significant increase39 while two studies reported a non- 
significant increase37 49 in hospital admissions for obese 
children compared with normal weight. Two studies 
reported a non- significant decrease in admissions.44 56 In 
addition, one study reported that 14.5% of obese or over-
weight children were admitted, compared with 16.5% 
normal- weight children.42 For overweight children, one 
study reported a significant decrease56 while one reported 
a non- significant decrease37 in admissions compared with 
normal- weight children.S
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Hospital LOS was reported as a measure of healthcare 
utilisation by six studies.46 47 52–54 57 Four studies found a 
significant increase in LOS for obese children compared 
with normal weight.46 47 52 54 One study reported a slight 
significant decrease in LOS for obese children,57 while 
one study reported no association between obese and 
normal- weight children.53
GP visits
Three studies reported GP visits as a measure for health-
care utilisation.48 55 58 All three studies reported a signif-
icant increase in GP visits for overweight and obese 
children, compared with their normal- weight peers.
Associated medical conditions
Five studies reported on the effect of asthma or acute 
respiratory disorders on healthcare utilisation in obese 
children.41 45–48 Of these studies, four reported that obese 
children significantly incurred increased healthcare use 
for asthma compared with normal- weight children.45–48 In 
addition, two studies found that other acute respiratory 
conditions are also significantly associated with increased 
healthcare use in obese children.41 45 Furthermore, two 
studies reported a non- significant increase for respiratory 
conditions in obese children.44 46
Two studies reported that obese children are at a signifi-
cantly greater risk of seeking healthcare for mental health 
problems compared with normal- weight children.37 44 
The risk for overweight children was also reported to be 
higher but non- significant. Two studies reported a non- 
significant increase in visits for musculoskeletal problems 
in obese children compared with normal- weight chil-
dren.44 50
BMI cut-offs
Table 1 shows that 20 of the included studies used the 
Centers for Disease Control or the International Obesity 
task force cut- off points to classify children into weight 
categories. However, some studies used the term ‘over-
weight’ in place of obese for ≥95% percentile, while 
using the term ‘at- risk of overweight (AROW)’ in place of 
overweight for children with BMI percentiles ≥85% and 
≤95%. During the analysis, we adjusted for this difference 
in terminologies.
Two studies used the weight for age BMI z- score classi-
fication.40 54 The effect size reported by these two studies 
for obese children was significant and much stronger 
than the studies not using this criterion. Three studies 
using data from German survey KiGGs and GINI and 
Figure 2 Forest plots showing the unadjusted effect sizes (rate ratios (RRs) with 95% CIs) for emergency department visits in 
(A) obese children, (B) overweight children. RRs are computed with normal- weight children as the reference category.
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LISA cohorts used the country- specific BMI cut- off values 
with obesity defined as >97th percentile.35 36 51 It was not 
possible to formally establish a comparison based on BMI 
cut- off criteria due to the small number of studies using 
respective BMI cut- offs and the use of different outcome 
measures across these studies.
Ethnicity
Two studies reported the effect of ethnicity on the asso-
ciation of weight status with healthcare utilisation.30 59 
Both these studies were from the USA. They reported a 
decrease in healthcare utilisation in black overweight or 
obese children compared with white overweight or obese 
children. In addition, one study also reported decreased 
healthcare use in obese Asian or Hispanic children 
compared with white obese children.30
Anthropometric measurements
Seven studies recorded the height and weight by 
self- reporting or parental reporting without valida-
tion.30–34 51 52 Five of these studies used data from MEPS 
survey in the USA. Variability in the direction and strength 
of association between weight status and healthcare use 
was observed across these studies. This heterogeneity 
could be subject to reporting bias due to self- reporting 
or parent- reporting; however, not enough data were avail-
able to formally assess this.
DISCUSSION
This systematic review and meta- analysis has demon-
strated an association between excess weight and 
increased healthcare use in children. Thirty- three studies 
were included in the review, of which six had appropriate 
data to be included in the meta- analysis. Attesting to the 
diverse nature of health services and the variability in 
their provision in different countries, the studies used 
multiple outcome measures to define healthcare utili-
sation. Commonly examined outcome measures were 
outpatient visit, ED visit, hospital admission and hospital 
LOS. Studies included in the meta- analysis reported an 
increased risk of healthcare utilisation in obese children 
compared with normal- weight children. A significant 
Figure 3 Forest plots showing the unadjusted effect sizes (rate ratios (RRs) with 95% CIs) for outpatient visits in (A) obese 
children, (B) overweight children. RRs are computed with normal- weight children as a reference category.
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unadjusted positive association of obesity with increased 
outpatient and ED visits was observed in the meta- analysis. 
The results of the narrative synthesis supported these 
findings and indicated that obese children are much 
more likely to have higher healthcare utilisation for all 
the reported outcome measures. However, variability in 
the direction and strength of association was observed 
across studies, with a few studies reporting a negative or 
no association.
A vast body of research and associated systematic 
reviews exist which have analysed the burden of adult 
obesity on healthcare systems and also the incremental 
health burden of child obesity during adulthood.60–62 
Such studies have indicated repeatedly that obesity is 
significantly related to a greater risk of morbidity in adult 
life and associated increase in healthcare utilisation. 
Our review builds on this knowledge and suggests that 
much like adult life, obesity during childhood results in 
an increased burden of morbidity on healthcare services. 
These findings can be explained in the light of recent 
clinical research reporting an increasing prevalence of 
obesity- related conditions in childhood that were more 
commonly associated with adulthood in the past.7 63
This leads our discussion into one of the secondary 
objectives of the review: to analyse the most common 
obesity- associated health conditions that are contributing 
to an increased healthcare use in children with obesity. 
Most of the included studies did not attempt to ascer-
tain the reason for increased healthcare utilisation. Two 
studies included in the review analysed the rate of mental 
health related visits in obese children, with both reporting 
an increased risk. These findings support the previous 
evidence that has shown obesity to be a strong risk factor 
for stigmatisation and development of low self- esteem 
and other mental health issues in children.64 65 The role 
of obesity in increasing the risk of asthma in children is 
well founded.66 Five studies in the review supported the 
previous evidence and reported that obesity leads to 
increased health service utilisation in asthmatic children 
and also in children with other respiratory diseases.
Regional variation in rates of healthcare utilisation is 
well reported in literature.67–69 When studies conducted 
in different regions or countries with different popula-
tion characteristics and healthcare systems are systemat-
ically reviewed and analysed together, regional variation 
in healthcare utilisation may result in between- study 
heterogeneity. Evidence suggests that this regional vari-
ation is in part driven by population- specific factors such 
as ethnicity, socioeconomic status, health status, cultural 
beliefs and preferences.68 The prevalence of childhood 
obesity varies between different regions and countries. It 
is also well reported that within a population, the prev-
alence of obesity varies between children of different 
ethnic origins.3 70 71 In addition, evidence shows an 
inverse relationship between the prevalence of obesity 
and low socioeconomic status.3 72 The extent to which 
this variability in prevalence translates into variability in 
associated morbidity and healthcare use is not known. 
There is evidence that healthcare seeking behaviour 
and healthcare uptake varies across ethnic groups and 
socioeconomic classes.73–76 Most of this evidence suggest 
that people belonging to black and other minority 
ethnic groups are at a disadvantage in accessing health 
services.77 78 In addition, cultural beliefs and perceptions 
towards health status in general and weight status in 
particular may contribute to ethnic disparities in health-
care utilisation.79 80 None of the studies included in the 
review analysed the impact of socioeconomic status while 
only two studies analysed the impact of ethnicity. They 
reported a significantly lower use of health services in 
obese children of black, Asian and other ethnic minority 
groups compared with white children. To what extent this 
lower use is a result of disadvantage in access to healthcare 
and what results from differences in prevalence and in 
levels of morbidity remains unclear. In addition, both of 
these studies were from the USA, which has specific health 
insurance programmes for children.81 82 Therefore, care 
should be taken in generalising these findings to other 
countries with different healthcare systems. In the light 
of these two studies and previous research evidence, we 
can infer that ethnicity and socioeconomic status could 
be sources of between- study heterogeneity reported in 
this review; however, as the studies did not report the 
ethnic and socioeconomic characteristics of the popula-
tions studied, it was not possible to explore this further. 
Evidence also suggests that in addition to population- 
specific factors, regional variation in healthcare is in part 
due to differences in region- specific factors such as access 
to health services, healthcare resources, health policies 
and physician beliefs.68 69 For example, some percentage 
of the between- study heterogeneity reported in our review 
may be attributable to regional variations in physician 
beliefs towards excess weight or barriers and facilitators 
to healthcare access. However, exploring the extent of 
heterogeneity due to region- specific variables was beyond 
the scope of this review.
Strengths and limitations
This review has a number of strengths. First, to our knowl-
edge this is the first systematic review and meta- analysis of 
the utilisation of healthcare services in obese and over-
weight children. Second, we have used a comprehensive 
search strategy, with publications not restricted by region 
or year of publication which resulted in the inclusion of 
33 studies reporting outcome measures from primary and 
secondary healthcare. In addition, a protocol was devel-
oped and registered a priori and methodological guide-
lines were followed on conducting and reporting a review.
A limitation of this review was the restriction of studies 
to English- language reports only. A limitation of the meta- 
analysis was the inclusion of only six studies which meant 
we were unable to include all the outcomes described in 
the review. In addition, there was uncertainty over the 
weighted effect sizes due to between- study heterogeneity 
in methods and outcomes.
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There were some further limitations in terms of the char-
acteristics of the included studies. First, the majority of 
the studies were from the USA, with the remainder being 
from eight first- world countries, therefore limiting the 
extent to which the findings may be generalised beyond 
certain national contexts due to differences in healthcare 
services and systems. Second, there was poor reporting 
of data for key study characteristics. For example, none 
of the studies included in the meta- analysis reported the 
use of healthcare services stratified by sex. Therefore, it 
was not possible to run a subset analysis and adjust for 
covariates in a meta- regression to formally analyse sources 
of between- study heterogeneity.
CONCLUSIONS
In summary, this systematic review has shown that over-
weight and obesity in children is positively associated 
with increased utilisation of ED and outpatient health-
care services during childhood. This finding remained 
in the meta- analysis although with potential heteroge-
neity between studies. The reported evidence for inpa-
tient health service use is mixed. The studies included in 
the review are limited to only a few developed countries; 
therefore, it is difficult to generalise these findings to 
other countries due to differences in healthcare systems 
and delivery of health services. The substantial between- 
study heterogeneity reported in the review might be due 
to these differences across countries; however, it was 
not possible to formally analyse this due to insufficient 
data. The review has identified areas of research where 
gaps exist. In particular, further research is required in 
understanding the dynamics of obesity- associated health 
conditions that may drive increased healthcare utilisation 
in children. In addition, the driving factors behind the 
varying effect of ethnicities and socioeconomic status on 
association of obesity with healthcare utilisation are yet 
to be explored. Such evidence is necessary for the devel-
opment of policies for clinical practice and research, and 
for their implementation in a way that, while being cost- 
effective, can successfully target the therapeutic needs of 
obese and overweight children from different ethnic and 
socioeconomic backgrounds.
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PRISMA 2009 Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
9 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
9 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions 
at each stage, ideally with a flow diagram.  
10 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
Table 1 
(page 11 – 
17) 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Table 2 
(page 18-
21) 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
22-25 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  22, 23 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  22 23 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  24 25, 26, 
27 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance 
to key groups (e.g., healthcare providers, users, and policy makers).  
28, 29 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
30 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  31 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 
the systematic review.  
32 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
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PRISMA 2009 Checklist 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Supplementary information: Search strategy for databases 
 
1. MEDLINE (Ovid) 
 
1. child*.mp. or Child/ 
2. Adolescent/ or adolescent*.mp. 
3. pediatric*.mp. 
4. teen*.mp. 
5. infant*.mp. or exp INFANT/ 
6. 1 or 2 or 3 or 4 or 5 
7. Body Weight/ or body weight*.mp. 
8. Obesity/ 
9. Body Mass Index/ 
10. obese.mp. or Overweight/ 
11. 7 or 8 or 9 or 10 
12. tertiary care.mp. or exp Tertiary Healthcare/ 
13. primary care.mp. or exp Primary Health Care/ 
14. secondary care.mp. or exp Secondary Care/ 
15. prescription*.mp. or exp PRESCRIPTION DRUGS/. 
16. health visit*.mp 
17. health resource*.mp. or exp Health Resources/ 
18. outpatient*.mp. or OUTPATIENT CLINICS, HOSPITAL/ 
19. hospital*.mp. 
20. exp Health Services/ or health servic*.mp. 
21. emergency care.mp. or exp Emergency Medical Services/ 
22. exp HEALTH EXPENDITURES/ or expenditure*.mp. 
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23. exp Health Care Costs/ or health care cost*.mp. 
24. General Practice/ or general practi*.mp. 
25. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24  
26. 6 and 11 and 25 
27. limit 26 to (english language and humans) 
 
2. PubMed 
 
(((((("Child"[Mesh]) OR "Adolescent"[Mesh]) OR "Infant"[Mesh]) OR teen[Text Word] OR child 
[Text Word] OR adolescent[Text Word] AND (((("Pediatric Obesity"[Mesh]) OR "Body Mass 
Index"[Mesh]) OR obesity[Text Word] OR adiposity[Text Word] AND ((((((((("Emergency Medical 
Services"[Mesh]) OR "Primary Health Care"[Mesh]) OR "Child Health Services"[Mesh]) OR 
"Adolescent Health Services"[Mesh]) OR "Health Services"[Mesh]) OR "Outpatient Clinics, 
Hospital"[Mesh]) OR "General Practice"[Mesh]) OR "Emergency Service, Hospital"[Mesh]) OR 
health visit[Text Word] AND "Humans"[Mesh] AND (english[Filter]) 
 
3. Web of Science 
 
1. TOPIC: (child*) OR TOPIC: (pediatric*) OR TOPIC: (adolescen*) OR TOPIC: (infant*) 
2. TOPIC: (primary care) OR TOPIC: (medical care) OR TOPIC: (healthcare) OR TOPIC: 
(tertiary care) OR TOPIC: (emergency care) OR TOPIC: (outpatient*) OR TOPIC: (prescription*) 
OR TOPIC: (health service*) OR TOPIC: (healthcare utilization) OR TOPIC: (healthcare cost) OR 
TOPIC: (general practi*) OR TOPIC: (health visit*) 
3. TS=(obes*) OR TS=(adipos*) OR TS=(body mass index*) OR TS=(overweight*) 
4. #3 AND #2 AND #1 
5. #3 AND #2 AND #1  
6. Refined by: LANGUAGES: (ENGLISH) 
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4. EMBASE 
 
1. child*.mp. or exp CHILD/ 
2. pediatric*.mp. 
3. exp Adolescent/ or adolescen*.mp. 
4. exp INFANT/ or infant*.mp 
5. 1 or 2 or 3 or 4 
6. exp Obesity/ or obes*.mp. 
7. exp Body Mass Index/ 
8. adipos*.mp. or exp Adiposity/ 
9. exp OVERWEIGHT/ or overweight*.mp. 
10. 6 or 7 or 8 or 9 
11. primary care.mp. or exp Primary Health Care/ 
12. tertiary care.mp. or exp Tertiary Healthcare/ 
13. prescription*.mp. or exp PRESCRIPTION DRUGS/ 
14. health visit*.mp. 
15. outpatient*.mp. or exp OUTPATIENT CLINICS, HOSPITAL/ 
16. exp Emergency Medical Services/ or emergency care*.mp. 
17. exp HEALTH EXPENDITURES/ or expenditure*.mp 
18. exp General Practice/ or general practi*.mp. 
19. exp Health Care Costs/ or health care cost*.mp. 
20. health resource*.mp. or exp Health Resources/ 
21. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
22. 5 and 10 and 21 
23. limit 22 to (human and english language) 
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